These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 29217878)
1. A Randomized Controlled Trial of Intravenous versus Oral Cyclophosphamide in Steroid-resistant Nephrotic Syndrome in Children. Shah KM; Ohri AJ; Ali US Indian J Nephrol; 2017; 27(6):430-434. PubMed ID: 29217878 [TBL] [Abstract][Full Text] [Related]
2. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Prasad N; Gulati S; Sharma RK; Singh U; Ahmed M Pediatr Nephrol; 2004 May; 19(5):494-8. PubMed ID: 15015070 [TBL] [Abstract][Full Text] [Related]
8. Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease. Haddad M; Kale A; Butani L BMC Nephrol; 2021 Nov; 22(1):395. PubMed ID: 34839817 [TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Colquitt JL; Kirby J; Green C; Cooper K; Trompeter RS Health Technol Assess; 2007; 11(21):iii-iv, ix-xi, 1-93. PubMed ID: 17537341 [TBL] [Abstract][Full Text] [Related]
10. Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children. Al Salloum AA Ann Saudi Med; 2004; 24(1):27-30. PubMed ID: 15310010 [TBL] [Abstract][Full Text] [Related]
11. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis. Rennert WP; Kala UK; Jacobs D; Goetsch S; Verhaart S Pediatr Nephrol; 1999 Feb; 13(2):113-6. PubMed ID: 10228995 [TBL] [Abstract][Full Text] [Related]
13. Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting. Saiteja P; Deepthi B; Krishnasamy S; Sravani M; Krishnamurthy S Pediatr Nephrol; 2024 Apr; 39(4):1149-1160. PubMed ID: 37947902 [TBL] [Abstract][Full Text] [Related]
14. Intravenous pulse cyclophosphamide therapy in focal segmental glomerulosclerosis. Buyukcelik M; Cengiz N; Dursun H; Soran M; Bayazit AK; Noyan A; Anarat A Clin Nephrol; 2006 Jan; 65(1):7-12. PubMed ID: 16429836 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300 [TBL] [Abstract][Full Text] [Related]
16. Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome? Alshaya HO; Al-Maghrabi JA; Kari JA Pediatr Nephrol; 2003 Nov; 18(11):1143-6. PubMed ID: 13680329 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome. Mantan M; Sriram CS; Hari P; Dinda A; Bagga A Pediatr Nephrol; 2008 Sep; 23(9):1495-502. PubMed ID: 18566839 [TBL] [Abstract][Full Text] [Related]
20. Treatment of steroid resistant nephrotic syndrome in children. Kari JA; Halawani M Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]